abstract |
(57) [Summary]nThe present invention relates to compounds that inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention further relates to chemotherapeutic compositions comprising the above compounds and to methods of inhibiting farnesyl-protein transferase and treating cancer. |